Consensus Document
Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)
Recomendaciones del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC) de la AEDV en relación con la realización de pruebas epicutáneas durante la pandemia por SARS-CoV-2 (COVID-19)
J.M. Carrascosaa,
, M.A. Pastor-Nietob, I. Ruiz-Gonzálezc, J.F. Silvestred, L. Borregoe, M.E. Gatica-Ortegaf, A.M. Giménez-Arnaug
Corresponding author
a Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain
b Servicio de Dermatología, Hospital Universitario de Guadalajara, Guadalajara, Spain
c Servicio de Dermatología, Complejo Asistencial Universitario de León, León, Spain
d Servicio de Dermatología, Hospital General Universitario de Alicante, Alicante, Spain
e Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain
f Servicio de Dermatología, Complejo Hospitalario Universitario de Toledo, Toledo, Spain
g Servicio de Dermatología, Parc de Salut Mar, Barcelona, Spain
Read
15532
Timeswas read the article
2291
Total PDF
13241
Total HTML
Share statistics
array:24 [ "pii" => "S1578219020302560" "issn" => "15782190" "doi" => "10.1016/j.adengl.2020.06.003" "estado" => "S300" "fechaPublicacion" => "2020-10-01" "aid" => "2406" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "pgl" "cita" => "Actas Dermosifiliogr. 2020;111:650-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731020302210" "issn" => "00017310" "doi" => "10.1016/j.ad.2020.06.003" "estado" => "S300" "fechaPublicacion" => "2020-10-01" "aid" => "2406" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "pgl" "cita" => "Actas Dermosifiliogr. 2020;111:650-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Documento de consenso</span>" "titulo" => "Recomendaciones del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC) de la AEDV en relación con la realización de pruebas epicutáneas durante la pandemia por SARS-CoV-2 (COVID-19)" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "650" "paginaFinal" => "654" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:2 [ 0 => array:2 [ "autoresLista" => "J.M. Carrascosa, M.A. Pastor-Nieto, I. Ruiz-González, J.F. Silvestre, L. Borrego, M.E. Gatica-Ortega, A.M. Giménez-Arnau" "autores" => array:8 [ 0 => array:2 [ "nombre" => "J.M." "apellidos" => "Carrascosa" ] 1 => array:2 [ "nombre" => "M.A." "apellidos" => "Pastor-Nieto" ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Ruiz-González" ] 3 => array:2 [ "nombre" => "J.F." "apellidos" => "Silvestre" ] 4 => array:2 [ "nombre" => "L." "apellidos" => "Borrego" ] 5 => array:2 [ "nombre" => "M.E." "apellidos" => "Gatica-Ortega" ] 6 => array:2 [ "nombre" => "A.M." "apellidos" => "Giménez-Arnau" ] 7 => array:1 [ "colaborador" => "en representación del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC)" ] ] ] 1 => array:2 [ "autoresLista" => "" "autores" => array:1 [ 0 => array:1 [ "colaborador" => "Miembros del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC)" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219020302560" "doi" => "10.1016/j.adengl.2020.06.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020302560?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020302210?idApp=UINPBA000044" "url" => "/00017310/0000011100000008/v1_202010020701/S0001731020302210/v1_202010020701/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S1578219020302663" "issn" => "15782190" "doi" => "10.1016/j.adengl.2020.09.009" "estado" => "S300" "fechaPublicacion" => "2020-10-01" "aid" => "2358" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2020;111:655-64" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic arthritis UnclutteRed Screening Evaluation (PURE4)" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:3 [ 0 => "en" 1 => "en" 2 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "655" "paginaFinal" => "664" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Adaptación lingüística y cultural al español del cuestionario para <span class="elsevierStyleItalic">Psoriatic arthritis UnclutteRed screening Evaluation</span> (PURE-4)" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0010" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 1058 "Ancho" => 1333 "Tamanyo" => 130405 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "I. Belinchón, R. Queiro, L. Salgado-Boquete, A. López-Ferrer, M. Ferran, P. Coto-Segura, R. Rivera, D. Vidal, L. Rodríguez, P. de la Cueva, G. Guinea, V. Martin Vazquez" "autores" => array:12 [ 0 => array:2 [ "nombre" => "I." "apellidos" => "Belinchón" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "Queiro" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Salgado-Boquete" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "López-Ferrer" ] 4 => array:2 [ "nombre" => "M." "apellidos" => "Ferran" ] 5 => array:2 [ "nombre" => "P." "apellidos" => "Coto-Segura" ] 6 => array:2 [ "nombre" => "R." "apellidos" => "Rivera" ] 7 => array:2 [ "nombre" => "D." "apellidos" => "Vidal" ] 8 => array:2 [ "nombre" => "L." "apellidos" => "Rodríguez" ] 9 => array:2 [ "nombre" => "P." "apellidos" => "de la Cueva" ] 10 => array:2 [ "nombre" => "G." "apellidos" => "Guinea" ] 11 => array:2 [ "nombre" => "V." "apellidos" => "Martin Vazquez" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0010"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731020301344" "doi" => "10.1016/j.ad.2020.03.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020301344?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020302663?idApp=UINPBA000044" "url" => "/15782190/0000011100000008/v1_202011031011/S1578219020302663/v1_202011031011/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S1578219020302675" "issn" => "15782190" "doi" => "10.1016/j.adengl.2020.03.015" "estado" => "S300" "fechaPublicacion" => "2020-10-01" "aid" => "2351" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2020;111:639-49" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Practical Dermatology</span>" "titulo" => "Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Hair Loss, and Hirsutism" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "639" "paginaFinal" => "649" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Uso de la espironolactona en dermatología: acné, hidradenitis supurativa, alopecia femenina e hirsutismo" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. Vargas-Mora, D. Morgado-Carrasco" "autores" => array:2 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Vargas-Mora" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Morgado-Carrasco" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731020301277" "doi" => "10.1016/j.ad.2020.03.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020301277?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020302675?idApp=UINPBA000044" "url" => "/15782190/0000011100000008/v1_202011031011/S1578219020302675/v1_202011031011/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Consensus Document</span>" "titulo" => "Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "650" "paginaFinal" => "654" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J.M. Carrascosa, M.A. Pastor-Nieto, I. Ruiz-González, J.F. Silvestre, L. Borrego, M.E. Gatica-Ortega, A.M. Giménez-Arnau" "autores" => array:7 [ 0 => array:4 [ "nombre" => "J.M." "apellidos" => "Carrascosa" "email" => array:1 [ 0 => "jmcarrascosac.germanstrias@gencat.cat" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "M.A." "apellidos" => "Pastor-Nieto" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "I." "apellidos" => "Ruiz-González" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "J.F." "apellidos" => "Silvestre" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "L." "apellidos" => "Borrego" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "M.E." "apellidos" => "Gatica-Ortega" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "A.M." "apellidos" => "Giménez-Arnau" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario de Guadalajara, Guadalajara, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Dermatología, Complejo Asistencial Universitario de León, León, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital General Universitario de Alicante, Alicante, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Dermatología, Complejo Hospitalario Universitario de Toledo, Toledo, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Dermatología, Parc de Salut Mar, Barcelona, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Recomendaciones del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC) de la AEDV en relación con la realización de pruebas epicutáneas durante la pandemia por SARS-CoV-2 (COVID-19)" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The rapid spread of infection by the coronavirus SARS-CoV-2 and the disease associated with this virus (COVID-19) constitute a serious public health problem.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The SARS-CoV-2 pandemic has led to the suspension of most contact dermatitis units and patch testing services because of the need for hospitals to prioritize treatment of COVID-19.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">As the pandemic is gradually coming under control, we must now consider the requirements, limitations, and conditioning factors affecting resumption of work in contact dermatitis units in a scenario in which the virus is still circulating and occasional or seasonal exacerbation episodes are possible.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The risk of spread of SARS-CoV-2 in contact dermatitis units is unknown, although common areas in these units follow similar disinfection protocols to those of other hospital services. However, in contact dermatitis units, which generally have specific consulting rooms with constant movement of physicians and nurses, contact with patients is closer and longer over time, with several visits in a few days. This close contact entails specific problems with respect to safety and the spread of SARS-CoV-2 between health professionals and between patients and health professionals.</p><p id="par0025" class="elsevierStylePara elsevierViewall">With the aim of balancing the risks and benefits for patients and optimizing safety for staff in charge of patient visits and diagnostic tests, the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC) of the Spanish Academy of Dermatology and Venereology has drawn up the following recommendations:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">•</span><p id="par0030" class="elsevierStylePara elsevierViewall">The number of patch tests should be adapted to the possibilities of the individual center based on relevant safety factors. In other words, a reasonable number of patients should be scheduled depending on their specific characteristics and on other simultaneous consultations in order to avoid crowding in the waiting room or overlapping appointments (e.g., 1  patient per hour, 5-6  patients per week). Consequently, it may be advisable to restrict the indication for patch testing to those cases where it is likely to have greater diagnostic yield, at least until the risk of infection has decreased.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">•</span><p id="par0035" class="elsevierStylePara elsevierViewall">The waiting list should be reviewed in order to prioritize patients depending on disease severity and urgency. Appendix <a class="elsevierStyleCrossRef" href="#sec0010">B</a> provides a detailed list of conditions that should be prioritized, although the attending physician’s evaluation should prevail in each case.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">•</span><p id="par0040" class="elsevierStylePara elsevierViewall">Alternatively, the patient should be given the option of postponing patch testing, especially in high-risk cases (elderly patients or patients with risk conditions for COVID [cardiovascular disease, diabetes, arterial hypertension, obesity, chronic respiratory disease, liver disease, cancer, and immunosuppression]). Similarly, and based on medical criteria, patch testing can be postponed in patients with mild or moderate eczema at sites not considered a priority and not active in recent months or with little impact on quality of life.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">•</span><p id="par0045" class="elsevierStylePara elsevierViewall">If feasible, we can provide the patient with scanned copies of all the necessary documentation relating to the tests (information, regimens, informed consent documents) by e-mail and receive the documents signed via the same channel. The e-mail should be official and not sent as an individual message from the patch testing team.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">•</span><p id="par0050" class="elsevierStylePara elsevierViewall">If available, the first visit can be virtual in the case of patch testing indicated by an external physician or physician other than the attending physician at the contact dermatitis unit. In this case, patch testing should be preceded by an online visit, with or without images and/or video. Thus, based on the individual clinical history, this approach would make it possible to prioritize patients whose diagnosis would be optimized with patch testing. Patients can provide information for the history, complete a questionnaire (e.g., history of atopy, occupational details, and contact allergens), send photographs of the lesions and of their own products (and of the ingredients in the case of personal care products) or of the summary of product characteristics in the case of occupational contact allergens.</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">•</span><p id="par0055" class="elsevierStylePara elsevierViewall">During the days before patch testing, patients should be contacted by telephone to ensure that they or the people they live with or the people they have been in recent contact with do not have symptoms of COVID-19. The symptoms to be asked about are shown in a questionnaire (Appendix <a class="elsevierStyleCrossRef" href="#sec0015">C</a>). Testing will be postponed in the case of patients who have tested positive for COVID-19. These patients should then be referred to their health center in order to adhere to the protocols established for each center and region. Similarly, before each face-to-face visit, patients must be asked about signs or symptoms that are suggestive of COVID-19 (questionnaire in Appendix <a class="elsevierStyleCrossRef" href="#sec0010">B</a>). When COVID-19 is suspected, patch testing should be postponed until the infection can be confirmed or ruled out. Given that some patients may not have symptoms or a detectable viral load before developing symptoms, the absence of the symptoms should not lead us to neglect general safety measures. In the case of patients who present with signs or symptoms that are suggestive of COVID-19 after performance of patch testing and before the reading, priority will be given to virtual methods of reading and interpretation. If this is not possible, and depending on the individual situation, patch testing can be postponed or the reading performed in a specific area for patients who are positive for COVID-19 and using appropriate personal protective equipment. Patients should receive specific recommendations, preferably before patch testing (Appendix <a class="elsevierStyleCrossRef" href="#sec0020">D</a>).</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">•</span><p id="par0060" class="elsevierStylePara elsevierViewall">The procedures followed for patch testing should be adapted to appropriate safety requirements for the SARS-CoV-2 pandemic (Appendix <a class="elsevierStyleCrossRef" href="#sec0025">E</a>).</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">•</span><p id="par0065" class="elsevierStylePara elsevierViewall">Visit for reading/interpretation of patch test results (48-96 h). The first reading should be taken immediately after removal of the patches. In equivocal cases, we should wait half an hour following the previously established safety recommendations. In specific cases, we can turn to teledermatology, which enables patients to send images they themselves have taken. Similarly, a video consultation will enable us to visualize the outcome of the examination, provide an interpretation, and record results in the clinical history, with recommendations for the patient. At this visit, we should calculate the time necessary to resolve doubts and send all the documentation (e.g., report, avoidance measures, treatment, and new appointments).</p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">•</span><p id="par0070" class="elsevierStylePara elsevierViewall">These actions will make it possible to reduce the number of in-person visits, although not the time taken by and assigned to the physician for medical procedures. This may be even longer, given the need for a strict protocol and additional requirements. In other words, quality and detail should be preferred over quantity.</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">•</span><p id="par0075" class="elsevierStylePara elsevierViewall">These procedures should be based on circuits that guarantee the confidentiality and reliability of digitally transmitted data.</p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">•</span><p id="par0080" class="elsevierStylePara elsevierViewall">All of these recommendations are suggestions, which can be adapted to the requirements and possibilities of the individual health center.</p></li></ul></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2020-06-09" "fechaAceptado" => "2020-06-13" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1287854" "palabras" => array:5 [ 0 => "Dermatitis" 1 => "COVID-19" 2 => "Patch testing" 3 => "Telemedicine" 4 => "Contact" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1287855" "palabras" => array:5 [ 0 => "Dermatitis" 1 => "COVID-19" 2 => "Epicutáneas" 3 => "Telemedicina" 4 => "Contacto" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">As the COVID-19 pandemic gradually comes under control, the members of the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC) have drawn up a proposed list of the requirements, limitations, and conditioning factors affecting the resumption of work in contact dermatitis units. The assumption is that the severe acute respiratory syndrome coronavirus 2 is still circulating and that occasional or seasonal outbreaks will occur. They recommend that the first step should be to assess how many patch tests each clinic can handle and review the waiting list to prioritize cases according to disease severity and urgency. Digital technologies can, where possible, be used to send and receive the documentation necessary for the patch test (information, instructions, informed consent, etc.). If the necessary infrastructure is available, patients can be offered the option of a remote initial consultation. Likewise, in selected cases, the patch test results can be read in a virtual visit using photographs taken by the patient or a video visit can be scheduled to allow the physician to evaluate the site of application remotely. These measures will reduce the number of face-to-face visits required, but will not affect the time spent on each case, which must be scheduled in the normal manner. All of these recommendations are suggestions and should be adapted to the needs and possibilities of each health centre.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Con el progresivo control de la pandemia por SARS-CoV-2, los miembros del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC) realizan una propuesta sobre cuáles van a ser los requisitos, las limitaciones y los condicionantes para reanudar el servicio en las unidades de dermatitis de contacto en un escenario en el que se presume la persistencia del virus, con episodios ocasionales o estacionales de exacerbación. Se aconseja ajustar el número de pruebas epicutáneas (PE) a las posibilidades de cada centro y la revisión de los casos en lista de espera para priorizar a los pacientes en función de la gravedad y la urgencia. Se ofrecerán, si es factible, métodos telemáticos para los documentos relativos a las PE (información, pautas, documentos de consentimiento informado). De estar disponible, puede ofrecerse la opción de realizar una primera visita telemática. Igualmente, en pacientes seleccionados puede llevarse a cabo una televisita en las visitas de lectura a través de imágenes realizadas por el paciente o mediante una videovisita que permita visualizar el resultado de la exploración. Estas acciones permitirán reducir el número de visitas presenciales, aunque no el tiempo dedicado y asignado al facultativo para los actos médicos. Todas estas recomendaciones son sugerencias y se adaptarán a los requisitos y a las posibilidades de cada centro sanitario.</p></span>" ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Carrascosa JM, Pastor-Nieto MA, Ruiz-González I, Silvestre JF, Borrego L, Gatica-Ortega ME, et al. Recomendaciones del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC) de la AEDV en relación con la realización de pruebas epicutáneas durante la pandemia por SARS-CoV-2 (COVID-19). Actas Dermosifiliogr. 2020;111:650–654.</p>" ] 1 => array:2 [ "etiqueta" => "◊" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">on behalf of Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC)</p>" ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:5 [ 0 => array:4 [ "apendice" => "<p id="par0085" class="elsevierStylePara elsevierViewall">José Carlos Armario Hita (Cádiz), Leopoldo Borrego Hernando (Las Palmas de Gran Canaria), José Manuel Carrascosa Carrillo (Barcelona), Susana Córdoba Guijarro (Madrid), Laia Curto (Barcelona), Virginia Fernández Redondo (Santiago de Compostela), Ignasi Figueras Nart (Barcelona), Juan García Gavín (Pontevedra), María Elena Gatica Ortega (Toledo), Anna Giménez Arnau (Barcelona), Elena Giménez Arnau (Barcelona), Enrique Gómez de la Fuente (Madrid), Ricardo González Pérez (Álava), Felipe Heras Mendaza (Madrid), Marcos Hervella Garcés (Pamplona), Pilar Manrique Martínez (Vizcaya), Pedro Mercader García (Murcia), Francisco Javier Ortiz de Frutos (Madrid), Javier Miquel Miquel (Valencia), María Antonia Pastor Nieto (Guadalajara), Mercedes Rodríguez Serna (Valencia), Inmaculada Ruíz González (León), Araceli Sánchez Gilo (Madrid), Paloma Sánchez-Pedreño Guillén (Murcia), Javier Sánchez Pérez (Madrid), Tatiana Sanz Sánchez (Madrid), Esther Serra-Baldrich (Barcelona), Juan Francisco Silvestre Salvador (Alicante), Violeta Zaragoza Ninet (Valencia).</p>" "etiqueta" => "Appendix A" "titulo" => "Members of the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)" "identificador" => "sec0005" ] 1 => array:4 [ "apendice" => "<p id="par0090" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">•</span><p id="par0095" class="elsevierStylePara elsevierViewall">Occupational eczema.</p></li><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">•</span><p id="par0100" class="elsevierStylePara elsevierViewall">Severe eczema.</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">•</span><p id="par0105" class="elsevierStylePara elsevierViewall">Eczema of the face or hands and widespread eczema that does not respond to appropriate treatment or protection measures.</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">•</span><p id="par0110" class="elsevierStylePara elsevierViewall">Acute recurrent eczema of unknown origin.</p></li><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">•</span><p id="par0115" class="elsevierStylePara elsevierViewall">Patients in whom dermatitis progresses with a high impact on quality-of-life.</p></li><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">•</span><p id="par0120" class="elsevierStylePara elsevierViewall">Patients who are to undergo a surgical or therapeutic intervention that cannot be delayed and for which the results of patch testing are essential (drugs, medical devices, glucose sensors/insulin pumps, dental intervention, orthopedic intervention, patients who are atopic before systemic therapy).</p></li></ul></p>" "etiqueta" => "Appendix B" "titulo" => "Conditions for Which Patch Testing Should Be Prioritized" "identificador" => "sec0010" ] 2 => array:4 [ "apendice" => "<p id="par0125" class="elsevierStylePara elsevierViewall">During the last 14 days, have you experienced any of the following symptoms?<ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">•</span><p id="par0130" class="elsevierStylePara elsevierViewall">Fever.</p></li><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">•</span><p id="par0135" class="elsevierStylePara elsevierViewall">Cough.</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">•</span><p id="par0140" class="elsevierStylePara elsevierViewall">Difficulty breathing.</p></li><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">•</span><p id="par0145" class="elsevierStylePara elsevierViewall">Muscle pain.</p></li><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">•</span><p id="par0150" class="elsevierStylePara elsevierViewall">Tiredness.</p></li><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">•</span><p id="par0155" class="elsevierStylePara elsevierViewall">Impairment or loss of sense of taste or a bitter taste with food and water.</p></li><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">•</span><p id="par0160" class="elsevierStylePara elsevierViewall">Reduced sense of smell or loss of sense of smell.</p></li><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">•</span><p id="par0165" class="elsevierStylePara elsevierViewall">Diarrhea.</p></li></ul></p> <p id="par0170" class="elsevierStylePara elsevierViewall">If you notice any of the symptoms, please call us and we will decide what to do. However, in principle, it would be best if you did not come to the hospital.</p> <p id="par0175" class="elsevierStylePara elsevierViewall">During the week you undergo testing, you should take your temperature every day and ensure that you do not have any of the symptoms mentioned above. Please contact us if you notice any symptoms.</p>" "etiqueta" => "Appendix C" "titulo" => "COVID Symptoms Questionnaire" "identificador" => "sec0015" ] 3 => array:4 [ "apendice" => "<p id="par0180" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">1</span><p id="par0185" class="elsevierStylePara elsevierViewall">Before coming to the center, please re-read the information on tests that we gave you when you came to your first visit or that you were sent by e-mail.</p></li><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">2</span><p id="par0190" class="elsevierStylePara elsevierViewall">Please keep to the time of your appointment. If you arrive early, please wait in the car. <span class="elsevierStyleSmallCaps">You must not arrive late</span>. We are trying to avoid crowding in the waiting rooms. We would be grateful if you would help by arriving at the allotted time.</p></li><li class="elsevierStyleListItem" id="lsti0140"><span class="elsevierStyleLabel">3</span><p id="par0195" class="elsevierStylePara elsevierViewall">Do not forget to bring your own products (shower gel, creams, and products for your skin condition). Please bring these in their original container.</p></li><li class="elsevierStyleListItem" id="lsti0145"><span class="elsevierStyleLabel">4</span><p id="par0200" class="elsevierStylePara elsevierViewall">Your own products will be placed in a clean bag and can be left in the hospital until testing is complete. You can also bring them and take them home again, although they must be here at each visit.</p></li><li class="elsevierStyleListItem" id="lsti0150"><span class="elsevierStyleLabel">5</span><p id="par0205" class="elsevierStylePara elsevierViewall">You are recommended to bring the signed informed consent document (you can send this by e-mail as a scanned document if this option is available at your center). Alternatively, you can sign the informed consent document during your first visit.</p></li><li class="elsevierStyleListItem" id="lsti0155"><span class="elsevierStyleLabel">6</span><p id="par0210" class="elsevierStylePara elsevierViewall">Please go to the toilet before leaving home so that you do not to have to do so in the hospital.</p></li><li class="elsevierStyleListItem" id="lsti0160"><span class="elsevierStyleLabel">7</span><p id="par0215" class="elsevierStylePara elsevierViewall">Please try to bring as few personal objects as possible (bag, fan, umbrella). If possible, try to make sure that these are washable. Please make sure your hair is tied up and avoid wearing jewelry.</p></li><li class="elsevierStyleListItem" id="lsti0165"><span class="elsevierStyleLabel">8</span><p id="par0220" class="elsevierStylePara elsevierViewall">Please try not to wear bracelets, watches, necklaces, or earrings on the day you undergo testing.</p></li><li class="elsevierStyleListItem" id="lsti0170"><span class="elsevierStyleLabel">9</span><p id="par0225" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleSmallCaps">You must be wearing a mask when you arrive, and you cannot remove it during your stay in the hospital.</span></p></li><li class="elsevierStyleListItem" id="lsti0175"><span class="elsevierStyleLabel">10</span><p id="par0230" class="elsevierStylePara elsevierViewall">You must enter the hospital unaccompanied unless you need help. Only minors or people with special needs (elderly and dependent persons) can be accompanied. Persons accompanying patients to the hospital must remain outside or in the car.</p></li><li class="elsevierStyleListItem" id="lsti0180"><span class="elsevierStyleLabel">11</span><p id="par0235" class="elsevierStylePara elsevierViewall">You must follow the recommendations of the staff at the center and maintain the recommended safe distance (1.5-2  m).</p></li><li class="elsevierStyleListItem" id="lsti0185"><span class="elsevierStyleLabel">12</span><p id="par0240" class="elsevierStylePara elsevierViewall">While in the hospital <span class="elsevierStyleSmallCaps">do not touch anything (e.g., doors, handles)</span> and maintain a safe distance from other people. Avoid crowding.</p></li><li class="elsevierStyleListItem" id="lsti0190"><span class="elsevierStyleLabel">13</span><p id="par0245" class="elsevierStylePara elsevierViewall">In the clinic, we will try to speak as little as necessary. Where possible, every effort will be made to send notifications and information by e-mail so that you do not have to take papers from the hospital to your home. If this is not possible, you will have to disinfect the papers when you arrive home or leave them in a safe place where they will not contaminate other objects.</p></li><li class="elsevierStyleListItem" id="lsti0195"><span class="elsevierStyleLabel">14</span><p id="par0250" class="elsevierStylePara elsevierViewall">Your belongings (e.g., clothing, bag) will be placed on the stretcher (clean sheets for each patient) or hung up in the consulting room. For your safety, please take care <span class="elsevierStyleSmallCaps">not to touch anything</span>. You will have to strip to the waist. The required test patches and your own products will be applied to your back.</p></li><li class="elsevierStyleListItem" id="lsti0200"><span class="elsevierStyleLabel">15</span><p id="par0255" class="elsevierStylePara elsevierViewall">We will give you the information about your next appointment by telephone or by e-mail. Wherever possible, we will try to keep your appointment at the same time throughout the week of patch testing.</p></li><li class="elsevierStyleListItem" id="lsti0205"><span class="elsevierStyleLabel">16</span><p id="par0260" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleSmallCaps">When you return home</span> from hospital on the days of your tests you must take the following precautions (and in the following order):<ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0210"><span class="elsevierStyleLabel">a</span><p id="par0265" class="elsevierStylePara elsevierViewall">Leave items such as bags and papers at the entrance.</p></li><li class="elsevierStyleListItem" id="lsti0215"><span class="elsevierStyleLabel">b</span><p id="par0270" class="elsevierStylePara elsevierViewall">Remove your shoes and leave them at the entrance.</p></li><li class="elsevierStyleListItem" id="lsti0220"><span class="elsevierStyleLabel">c</span><p id="par0275" class="elsevierStylePara elsevierViewall">Wash your hands with soap and water for 1  minute.</p></li><li class="elsevierStyleListItem" id="lsti0225"><span class="elsevierStyleLabel">d</span><p id="par0280" class="elsevierStylePara elsevierViewall">Remove your mask.</p></li><li class="elsevierStyleListItem" id="lsti0230"><span class="elsevierStyleLabel">e</span><p id="par0285" class="elsevierStylePara elsevierViewall">Remove your clothes.</p></li><li class="elsevierStyleListItem" id="lsti0235"><span class="elsevierStyleLabel">f</span><p id="par0290" class="elsevierStylePara elsevierViewall">Wash carefully <span class="elsevierStyleItalic">and try to keep the test area dry</span> (use a handheld shower, clean other areas and wash your hair separately in the sink).</p></li><li class="elsevierStyleListItem" id="lsti0240"><span class="elsevierStyleLabel">g</span><p id="par0295" class="elsevierStylePara elsevierViewall">Wash clothes in the washing machine at 60°.</p></li><li class="elsevierStyleListItem" id="lsti0245"><span class="elsevierStyleLabel">h</span><p id="par0300" class="elsevierStylePara elsevierViewall">Disinfect objects or materials that are likely to carry infection (e.g., phone, keys, bag) with alcohol.</p></li><li class="elsevierStyleListItem" id="lsti0250"><span class="elsevierStyleLabel">i</span><p id="par0305" class="elsevierStylePara elsevierViewall">Finally, wash your hands again very carefully.</p></li></ul></p></li></ul></p> <p id="par0310" class="elsevierStylePara elsevierViewall">You should follow these steps every time you return from the hospital.</p>" "etiqueta" => "Appendix D" "titulo" => "Information for Patients" "identificador" => "sec0020" ] 4 => array:4 [ "apendice" => "<p id="par0315" class="elsevierStylePara elsevierViewall"><ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0255"><span class="elsevierStyleLabel">•</span><p id="par0320" class="elsevierStylePara elsevierViewall">Organize the appointments list in order to avoid the accumulation of patients in the waiting room.</p></li><li class="elsevierStyleListItem" id="lsti0260"><span class="elsevierStyleLabel">•</span><p id="par0325" class="elsevierStylePara elsevierViewall">Ensure that the waiting room enables patients to maintain a distance of 1.5-2  m between each other.</p></li><li class="elsevierStyleListItem" id="lsti0265"><span class="elsevierStyleLabel">•</span><p id="par0330" class="elsevierStylePara elsevierViewall">Provide patients with hand sanitizer at the door and with a mask if they have not brought one from home.</p></li><li class="elsevierStyleListItem" id="lsti0270"><span class="elsevierStyleLabel">•</span><p id="par0335" class="elsevierStylePara elsevierViewall">There should be a clean, well-signposted circuit, in addition to staff who can inform patients and facilitate access to the clinic in order to prevent them from walking around the highest-risk areas.</p></li><li class="elsevierStyleListItem" id="lsti0275"><span class="elsevierStyleLabel">•</span><p id="par0340" class="elsevierStylePara elsevierViewall">If a patient has to partially undress, then he/she should have access, where possible, to an individual consulting room or stretcher where clothes can be left. Clothes will be kept in a disposable bag. It is important to ensure appropriate disinfection of surfaces and of other areas such as chairs and door handles between one patient and the next.</p></li><li class="elsevierStyleListItem" id="lsti0280"><span class="elsevierStyleLabel">•</span><p id="par0345" class="elsevierStylePara elsevierViewall">Gloves and mask should be worn when receiving patients, during the visit, and during the patch tests. The use of safety glasses or a face shield and an impermeable gown will be evaluated in specific cases (possible risk of aerosol transport).</p></li><li class="elsevierStyleListItem" id="lsti0285"><span class="elsevierStyleLabel">•</span><p id="par0350" class="elsevierStylePara elsevierViewall">Apply hand antiseptic (gel/water-alcohol solution) before and after each patient.</p></li><li class="elsevierStyleListItem" id="lsti0290"><span class="elsevierStyleLabel">•</span><p id="par0355" class="elsevierStylePara elsevierViewall">Collect the informed consent document in a plastic sheath supplied by the hospital (standard).</p></li><li class="elsevierStyleListItem" id="lsti0295"><span class="elsevierStyleLabel">•</span><p id="par0360" class="elsevierStylePara elsevierViewall">Apply tests using gloves that can be discarded after each patient.</p></li><li class="elsevierStyleListItem" id="lsti0300"><span class="elsevierStyleLabel">•</span><p id="par0365" class="elsevierStylePara elsevierViewall">Patch tests can be marked using adhesive material (preferably surgical steri-strip), individual acetate sheets, or 1 marker per patient. Disinfect the area to be marked with water-alcohol solution.</p></li><li class="elsevierStyleListItem" id="lsti0305"><span class="elsevierStyleLabel">•</span><p id="par0370" class="elsevierStylePara elsevierViewall">In the case of patients who bring their own products, these should be provided in individual bags and handled while wearing gloves</p></li><li class="elsevierStyleListItem" id="lsti0310"><span class="elsevierStyleLabel">•</span><p id="par0375" class="elsevierStylePara elsevierViewall">Establish appropriate ventilation of areas between one patient and the next.</p></li><li class="elsevierStyleListItem" id="lsti0315"><span class="elsevierStyleLabel">•</span><p id="par0380" class="elsevierStylePara elsevierViewall">During the removal of patches and the first reading, follow the procedures and recommendations indicated for application of the patch test.</p></li><li class="elsevierStyleListItem" id="lsti0320"><span class="elsevierStyleLabel">•</span><p id="par0385" class="elsevierStylePara elsevierViewall">During the week, give patients the option to store their own products in clean bags that can remain in the hospital until the tests are complete.</p></li></ul></p>" "etiqueta" => "Appendix E" "titulo" => "Instructions for Staff Who Perform Patch Testing: Suggestions That Should Be Adapted to Local Requirements" "identificador" => "sec0025" ] ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Exploring the impact of COVID-19 on progress towards achieving global surgery goals" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D. Mazingi" 1 => "S. Navarro" 2 => "M.C. Bobel" 3 => "A. Dube" 4 => "C. Mbanje" 5 => "C. Lavy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00268-020-05627-7" "Revista" => array:6 [ "tituloSerie" => "World J Surg" "fecha" => "2020" "volumen" => "44" "paginaInicial" => "2451" "paginaFinal" => "2457" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32488665" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Gisondi" 1 => "S. Piaserico" 2 => "A. Conti" 3 => "L. Naldi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jdv.16515" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2020" "volumen" => "34" "paginaInicial" => "1196" "paginaFinal" => "1201" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32320091" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of COVID-19 outbreak on dermatology services: dermatology in isolation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D. Katerina" 1 => "N. Lence" 2 => "S. Viktor" 3 => "P. Andrej" 4 => "D. Irena" 5 => "T. Natasa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/dth.13552" "Revista" => array:3 [ "tituloSerie" => "Dermatol Ther" "fecha" => "2020" "volumen" => "10" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011100000008/v1_202011031011/S1578219020302560/v1_202011031011/en/main.assets" "Apartado" => array:4 [ "identificador" => "6228" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Consensus document" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011100000008/v1_202011031011/S1578219020302560/v1_202011031011/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020302560?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 11 | 12 | 23 |
| 2024 October | 158 | 50 | 208 |
| 2024 September | 136 | 28 | 164 |
| 2024 August | 140 | 78 | 218 |
| 2024 July | 94 | 33 | 127 |
| 2024 June | 162 | 47 | 209 |
| 2024 May | 126 | 46 | 172 |
| 2024 April | 276 | 37 | 313 |
| 2024 March | 243 | 37 | 280 |
| 2024 February | 223 | 50 | 273 |
| 2024 January | 150 | 32 | 182 |
| 2023 December | 144 | 12 | 156 |
| 2023 November | 185 | 31 | 216 |
| 2023 October | 631 | 79 | 710 |
| 2023 September | 1017 | 83 | 1100 |
| 2023 August | 465 | 28 | 493 |
| 2023 July | 507 | 60 | 567 |
| 2023 June | 487 | 40 | 527 |
| 2023 May | 411 | 32 | 443 |
| 2023 April | 384 | 22 | 406 |
| 2023 March | 493 | 36 | 529 |
| 2023 February | 344 | 29 | 373 |
| 2023 January | 331 | 25 | 356 |
| 2022 December | 133 | 45 | 178 |
| 2022 November | 47 | 31 | 78 |
| 2022 October | 43 | 22 | 65 |
| 2022 September | 29 | 35 | 64 |
| 2022 August | 39 | 51 | 90 |
| 2022 July | 41 | 54 | 95 |
| 2022 June | 57 | 47 | 104 |
| 2022 May | 153 | 42 | 195 |
| 2022 April | 220 | 49 | 269 |
| 2022 March | 226 | 100 | 326 |
| 2022 February | 462 | 47 | 509 |
| 2022 January | 445 | 51 | 496 |
| 2021 December | 146 | 51 | 197 |
| 2021 November | 142 | 61 | 203 |
| 2021 October | 141 | 65 | 206 |
| 2021 September | 122 | 52 | 174 |
| 2021 August | 134 | 46 | 180 |
| 2021 July | 143 | 49 | 192 |
| 2021 June | 122 | 48 | 170 |
| 2021 May | 154 | 63 | 217 |
| 2021 April | 1903 | 113 | 2016 |
| 2021 March | 377 | 43 | 420 |
| 2021 February | 151 | 43 | 194 |
| 2021 January | 144 | 33 | 177 |
| 2020 December | 114 | 34 | 148 |
| 2020 November | 106 | 32 | 138 |
| 2020 October | 168 | 35 | 203 |
| 2020 September | 161 | 22 | 183 |
Show all
